研究疾病:
|
慢性疲劳综合征
|
研究疾病代码:
|
|
Target disease:
|
chronic fatigue syndrome
|
Target disease code:
|
研究类型:
Study type:
|
干预性研究
Interventional study
|
研究设计:
Study design:
|
随机平行对照
randomized controlled trial(parallel group design)
|
研究所处阶段:
Study phase:
|
其它
Others
|
研究目的:
|
1.针对CFS的诊断缺乏客观指标的现状,本研究利用对CFS高危人群的调查研究,在传统基于症状和量表进行诊断的基础上,筛查能够较好反应CFS发生和发展的客观生物指标,包括生化指标,电生理、反应时等生理指标,代谢标志物以及中医症候等,为完善CFS的诊断提供客观指标。
2. 利用调查研究筛查得到的以及普通门诊CFS人群开展CFS中医非药物特色疗法治疗多中心随机对照临床研究,以评价中医非药物特色干预的有效性和安全性。同时,通过观察调查研究阶段筛查得到的阳性生物标志物及中医症候在干预前后的变化情况,进一步验证其作为诊断和疗效评价指标,从而形成具有中医特色的CFS诊断标准和非药物干预特色疗法的治疗方案。
3.建设高质量的符合CDISC标准的CFS临床研究数据库,为后续CFS研究提供大数据支撑。
4.揭示中医非药物特色疗法干预 CFS 产生临床疗效的客观物质基础。
|
Objectives of Study:
|
1. In view of the lack of objective indicators for the diagnosis of CFS, this study uses investigations on high-risk populations of CFS. Based on traditional diagnosis based on symptoms and scales, screening can better reflect the occurrence and development of CFS objective biological indicators , Including biochemical indicators, electrophysiology, reaction time and other physiological indicators, metabolic markers and TCM symptoms, etc., to provide objective indicators for perfecting the diagnosis of CFS.
2. Use the results of the investigation and research screening and the general outpatient CFS population to carry out a multi-center randomized controlled clinical study of CFS non-drug characteristic treatment of TCM to evaluate the effectiveness and safety of TCM non-drug characteristic intervention. At the same time, by observing the positive biomarkers screened in the investigation and research stage and the changes of TCM symptoms before and after the intervention, they are further verified as diagnostic and efficacy evaluation indicators, thereby forming a CFS diagnostic standard with TCM characteristics and non-pharmaceutical intervention characteristic therapies Treatment options.
3. Build a high-quality CFS clinical research database that complies with CDISC standards to provide big data support for subsequent CFS research.
4. Reveal the objective material basis for the clinical curative effect of non-drug characteristic therapies of TCM intervention in CFS.
|
药物成份或治疗方案详述:
|
|
Description for medicine or protocol of treatment in detail:
|
|
纳入标准:
|
根据美国疾病控制与预防中心(CDC)1994年制定的CFS诊断标准,满足
a) 持久或反复发作的疲劳,持续在6个月以上;
b) 根据病史、体征或实验室检查结果,可以排除引起慢性疲劳的各种器质性疾病。
并且同时至少具备下列8项中的4项:
1)短期记忆力减退或者注意力不能集中;
2)咽痛;
3)淋巴结痛;
4)肌肉酸痛;
5)不伴有红肿的关节疼痛;
6)新发头痛;
7)睡眠后精力不能恢复;
8)体力或脑力劳动后连续24小时身体不适。
|
Inclusion criteria
|
According to the CFS diagnostic criteria established by the Centers for Disease Control and Prevention (CDC) in 1994, it meets the
a) Long-term or recurrent fatigue, lasting more than 6 months;
b) According to medical history, physical signs or laboratory test results, various organic diseases that cause chronic fatigue can be ruled out.
And have at least 4 of the following 8 items at the same time:
1) Short-term memory loss or inability to concentrate;
2) Sore throat;
3) Pain in lymph nodes;
4) Muscle aches;
5) Joint pain without redness and swelling;
6) New headache;
7) The energy cannot be recovered after sleep;
8) Consecutive 24 hours of physical discomfort after physical or mental work.
|
排除标准:
|
受试者满足以下任何一项均不予入组:
1)没有疲劳主诉,或伴随症状少于4个;
2)经休息后疲劳症状可以缓解;
3)疲劳症状并不引起工作能力、接受教育能力、社会活动娱乐活动以及个人生活能力的实质性下降;
4)患有肿瘤、糖尿病、风湿免疫病等可明确引起疲劳的疾病;
5)患有严重的心、肺、肝、肾功能异常者,甲状腺功能异常患者;
6)精神性疾病患者;
7)孕期和哺乳期妇女;
8)入组前7天内采用药物和非药物治疗;
9)同时在参加其他临床试验。
|
Exclusion criteria:
|
Subjects who meet any of the following will not be included in the group:
1) There is no chief complaint of fatigue, or fewer than 4 accompanying symptoms;
2) The fatigue symptoms can be relieved after rest;
3) The fatigue symptoms do not cause a substantial decrease in work ability, ability to receive education, social activities and entertainment activities, and personal life ability;
4) Suffer from tumor, diabetes, rheumatism and other diseases that can clearly cause fatigue;
5) Patients with severe heart, lung, liver, and kidney function abnormalities, and patients with abnormal thyroid function;
6) Patients with mental illness;
7) Women during pregnancy and lactation;
8) Adopt drug and non-drug treatment within 7 days before enrollment;
9) At the same time participating in other clinical trials.
|
研究实施时间:
Study execute time:
|
从From
2020-10-01
至To
2022-09-30
|
征募观察对象时间:
Recruiting time:
|
从From
2020-10-01
至To
2022-09-30
|